2018-07-12 |
102 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by Sigmapharm Laboratories, LLC. (Myer, …
2 September 2020
1:17-cv-00462
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-07-19 |
108 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by InvaGen Pharmaceuticals, Inc.. (Myer,…
2 September 2020
1:17-cv-00462
830 Patent
None
District Court, D. Delaware
|
External link to document |
2018-07-24 |
109 |
Order |
1-4 of U.S. Patent No. 9,539,218 ("the Asserted Claims of the '218 Patent"), provided…and Order Regarding Infringement of U.S. Patent No. 9,539,218. Signed by Judge Richard G. Andrews on 7… INFRINGEMENT OF U.S. PATENT NO. 9,539,218
Plaintiff Bayer Intellectual Property…infringement of the Asserted Claims of the '218 Patent,
provided the claim at issue is not proven invalid…infringement of the Asserted Claims of the '218 patent.
4. Nothing in this stipulation shall |
External link to document |
2019-03-22 |
150 |
Pretrial Order |
assert all four claims of U.S. Patent No. 9,539,218 (“the ’218 patent”).
2. By letter dated…the ’218 patent. Plaintiffs
timely filed complaints alleging infringement of the ’218 patent against …Legible, accurate copies of United States patents and foreign patents, as well as
their corresponding prosecutions… 1. This is a consolidated action for patent infringement under the Hatch-Waxman
Act. Plaintiffs…rivaroxaban
tablets prior to the expiration of the ’218 patent. Mylan’s letter also notified BIP and Janssen
|
External link to document |
2019-03-29 |
156 |
|
166:7
167:1 167:16
168:1 168:6
168:16 168:23
174:6 175:6
177:10 …reference to a U.S. patent or U.S. patent application publication, which patent or
patent application publication… I. The Patent-In-Suit
1. U.S. Patent No. 9,539,218 (“the ’218 patent”), entitled … on U.S. Patent No. 7,157,456 (“the ’456 patent”),
which is not prior art. The ’456 patent issued from… on U.S. Patent No. 7,592,339 (“the ’339 patent”), which is not
prior art. The ’339 patent issued from |
External link to document |
2019-04-02 |
157 |
Opinion |
tablet” in
claims 1–4 of U.S. Patent No. 9,539,218 (“the ’218 patent”). Before the court are Joint Pretrial… to the expiration of the ’218 patent.1
Claim 1 of the ’218 patent recites:
1. A method of treating…012897, which is referenced in the ’218 patent.
The ’218 patent specification states that “[p]reparation… reference.” ’218
patent, col. 8, ll. 28–30.
Mylan points out that the patent cites “the wrong number…well-settled that, in a patent infringement suit, a district court can construe a patent to
correct an obvious |
External link to document |
2019-11-04 |
191 |
Consent Judgment - Proposed |
infringement of United States Patent No. 9,539,218 (“the ’218 patent”);
WHEREAS Janssen currently…the term of the ’218 patent, including any patent term
extensions and/or patent term adjustments and …prior to the
expiration of the ’218 patent was a technical act of patent infringement with respect to the…prior to the
expiration of the ’218 patent was a technical act of patent infringement with respect to the…’218 patent under 35 U.S.C. §271(e)(2)(A).
3. The asserted claims of the ’218 patent are |
External link to document |